These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3123225)

  • 1. Reduction of myosin-light-chain phosphorylation and of parvalbumin content in myotonic mouse muscle and its reversal by tocainide.
    Jockusch H; Reininghaus J; Stuhlfauth I; Zippel M
    Eur J Biochem; 1988 Jan; 171(1-2):101-5. PubMed ID: 3123225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite regulation of the mRNAs for parvalbumin and p19/6.8 in myotonic mouse muscle.
    Kluxen FW; Schöffl F; Berchtold MW; Jockusch H
    Eur J Biochem; 1988 Sep; 176(1):153-8. PubMed ID: 3138114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myotonic mouse mutant ADR: electrophysiology of the muscle fiber.
    Mehrke G; Brinkmeier H; Jockusch H
    Muscle Nerve; 1988 May; 11(5):440-6. PubMed ID: 2453798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myotonic mouse mutant ADR: physiological and histochemical properties of muscle.
    Reininghaus J; Füchtbauer EM; Bertram K; Jockusch H
    Muscle Nerve; 1988 May; 11(5):433-9. PubMed ID: 2967431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental control of the excitability of muscle: transplantation experiments on a myotonic mouse mutant.
    Füchtbauer EM; Reininghaus J; Jockusch H
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3880-4. PubMed ID: 3375245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosin light chain phosphorylation-dephosphorylation in mammalian skeletal muscle.
    Manning DR; Stull JT
    Am J Physiol; 1982 Mar; 242(3):C234-41. PubMed ID: 7065172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tocainide on normal and myotonic mammalian skeletal muscle.
    Dengler R; Rüdel R
    Arzneimittelforschung; 1979; 29(2):270-3. PubMed ID: 582139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.
    Talon S; De Luca A; De Bellis M; Desaphy JF; Lentini G; Scilimati A; Corbo F; Franchini C; Tortorella P; Jockusch H; Conte Camerino D
    Br J Pharmacol; 2001 Dec; 134(7):1523-31. PubMed ID: 11724759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum parvalbumin, an indicator of muscle disease in murine dystrophy and myotonia.
    Jockusch H; Friedrich G; Zippel M
    Muscle Nerve; 1990 Jun; 13(6):551-5. PubMed ID: 2366828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-binding protein, parvalbumin, is reduced in mutant mammalian muscle with abnormal contractile properties.
    Stuhlfauth I; Reininghaus J; Jockusch H; Heizmann CW
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4814-8. PubMed ID: 6589628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the identities of five proteins decreased in skeletal muscle of dystrophic mice.
    Jasch LG; Moase EH
    Muscle Nerve; 1985 Jun; 8(5):389-401. PubMed ID: 16758585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Augmentation of gamma-myosin in human myotonic muscles].
    CARAFOLI E
    Riv Patol Nerv Ment; 1961 Oct; 82():54-64. PubMed ID: 13876422
    [No Abstract]   [Full Text] [Related]  

  • 13. Subtractive cDNA cloning as a tool to analyse secondary effects of a muscle disease. Characterization of affected genes in the myotonic ADR mouse.
    Schleef M; Zühlke C; Schöffl F; Jockusch H
    Neuromuscul Disord; 1994 May; 4(3):205-17. PubMed ID: 7522680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isomyosin distribution in skeletal muscles of normal and myotonic goats.
    Martin AF; Bryant SH; Mandel F
    Muscle Nerve; 1984 Feb; 7(2):152-60. PubMed ID: 6717492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
    De Luca A; Pierno S; Liantonio A; Desaphy JF; Natuzzi F; Didonna MP; Ferrannini E; Jockusch H; Franchini C; Lentini G; Corbo F; Tortorella V; Camerino DC
    Neuromuscul Disord; 2004 Jul; 14(7):405-16. PubMed ID: 15210163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in cross-bridge attachment rate and tension with phosphorylation of myosin in mammalian skinned skeletal muscle fibers. Implications for twitch potentiation in intact muscle.
    Metzger JM; Greaser ML; Moss RL
    J Gen Physiol; 1989 May; 93(5):855-83. PubMed ID: 2661721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid reduction in parvalbumin concentration during chronic stimulation of rabbit fast twitch muscle.
    Klug G; Reichmann H; Pette D
    FEBS Lett; 1983 Feb; 152(2):180-2. PubMed ID: 6572150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A developmental change in the content of parvalbumin in normal and dystrophic mouse (mdx) muscle.
    Sano M; Yokota T; Endo T; Tsukagoshi H
    J Neurol Sci; 1990 Jul; 97(2-3):261-72. PubMed ID: 2119423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of rabbit skeletal muscle myosin in situ.
    Moore RL; Houston ME; Iwamoto GA; Stull JT
    J Cell Physiol; 1985 Nov; 125(2):301-5. PubMed ID: 4055914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvalbumin in mouse muscle in vivo and in vitro.
    Ecob-Prince MS; Leberer E
    Differentiation; 1989 Mar; 40(1):10-6. PubMed ID: 2526037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.